Wall Street Analysts See a 41.29% Upside in NeuroPace (NPCE): Can the Stock Really Move This High?

Average Wall Street price targets imply a 41.3% upside for NeuroPace (NPCE). Analysts' earnings estimate revisions have been trending positive, which could support upside in the stock, but the price-target-average is a noisy metric and should be treated cautiously. This is an upside-biased signal rather than a definitive catalyst.

Analysis

Average Wall Street price targets imply a 41.3% upside for NeuroPace (NPCE). Analysts' earnings estimate revisions have been trending positive, which could support upside in the stock, but the price-target-average is a noisy metric and should be treated cautiously. This is an upside-biased signal rather than a definitive catalyst.